Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates
Open Access
- 2 August 2010
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 207 (9) , 2003-2017
Abstract
Broadly neutralizing antibodies (bNAbs) against the HIV-1 envelope glycoproteins (Envs) have proven difficult to elicit by immunization. Therefore, to identify effective Env neutralization targets, efforts are underway to define the specificities of bNAbs in chronically infected individuals. For a prophylactic vaccine, it is equally important to define the immunogenic properties of the heavily glycosylated Env in healthy primates devoid of confounding HIV-induced pathogenic factors. We used rhesus macaques to investigate the magnitude and kinetics of B cell responses stimulated by Env trimers in adjuvant. Robust Env-specific memory B cell responses and high titers of circulating antibodies developed after trimer inoculation. Subsequent immunizations resulted in significant expansion of Env-specific IgG-producing plasma cell populations and circulating Abs that displayed increasing avidity and neutralization capacity. The neutralizing activity elicited with the regimen used was, in most aspects, superior to that elicited by a regimen based on monomeric Env immunization in humans. Despite the potency and breadth of the trimer-elicited response, protection against heterologous rectal simian-HIV (SHIV) challenge was modest, illustrating the challenge of eliciting sufficient titers of cross-reactive protective NAbs in mucosal sites. These data provide important information for the design and evaluation of vaccines aimed at stimulating protective HIV-1 immune responses in humans.Keywords
This publication has 73 references indexed in Scilit:
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandNew England Journal of Medicine, 2009
- Germinal center reutilization by newly activated B cellsJournal of Experimental Medicine, 2009
- Towards an understanding of the adjuvant action of aluminiumNature Reviews Immunology, 2009
- A method for identification of HIV gp140 binding memory B cells in human bloodJournal of Immunological Methods, 2009
- Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challengeVirology, 2008
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virusNature, 2008
- GM-CSF DNA: An adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccineVirology, 2007
- Broad HIV-1 neutralization mediated by CD4-binding site antibodiesNature Medicine, 2007
- Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructsVaccine, 2007
- Quantitation of rare memory B cell populations by two independent and complementary approachesJournal of Immunological Methods, 2006